Key result
The novel CRISPR-Cas12a based assay detected African swine fever virus with a limit of detection of 1.16 copies/μl, demonstrating approximately ten times higher sensitivity than commercial qPCR.
Why the study?
Because no treatment or effective vaccine for African swine fever virus is currently available, a rapid and highly sensitive diagnostic was urgently needed to curb its spread.
Does a CRISPR-Cas12a based assay improve the detection sensitivity of African swine fever virus compared to standard qPCR in porcine samples?
Does a CRISPR-Cas12a based assay improve the detection sensitivity of African swine fever virus compared to standard qPCR in porcine samples?
The novel CRISPR-Cas12a based assay provides a highly sensitive, specific, and rapid method for detecting African swine fever virus, outperforming standard qPCR in limit of detection.
Answers are grounded in this paper and cite their sources.
CRISPR-Cas12a assay enables adaptable ASFV detection; leaves open real-world sensitivity across field samples and genotypes.
BACKGROUND: As no treatment or effective vaccine for African swine fever virus (ASFV) is currently available, a rapid, highly sensitive diagnostic is urgently needed to curb the spread of ASFV. RESULTS: Here we designed a novel CRISPR-Cas12a based assay for ASFV detection. To detect different ASFV genotypes, 19 crRNAs were designed to target the conserved p72 gene in ASFV, and several crRNAs with high activity were identified that could be used as alternatives in the event of new ASFV variants. The results showed that the sensitivity of the CRISPR-Cas12a based assay is about ten times higher than either the commercial quantitative PCR (qPCR) kit or the OIE-recommended qPCR. CRISPR-Cas12a based assay could also detect ASFV specifically without cross-reactivity with other important viruses in pigs and various virus genotypes. We also found that longer incubation times increased the detection limits, which could be applied to improve assay outcomes in the detection of weakly positive samples and new ASFV variants. In addition, both the CRISPR-Cas12a based assay and commercial qPCR showed very good consistency. CONCLUSIONS: In summary, the CRISPR-Cas12a based assay offers a feasible approach and a new diagnostic technique for the diagnosis of ASFV, particularly in resource-poor settings.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2020) studied African swine fever virus (ASFV) (n=101). CRISPR-Cas12a based assay vs. Commercial qPCR kit and OIE-recommended qPCR was evaluated on Limit of detection (sensitivity). The novel CRISPR-Cas12a based assay detected African swine fever virus with a limit of detection of 1.16 copies/μl, demonstrating approximately ten times higher sensitivity than commercial qPCR.
Synapse has enriched 10 related papers. Consider them for comparative context: